Search hospitals

>

Michigan

>

Grosse Pointe

Ascension St John Hospital

Claim this profile

Grosse Pointe, Michigan 48236

Conducts research for Lymphoma

Conducts research for Breast Cancer

Conducts research for Childhood Blood Disease

Conducts research for Mixed-Cell Lymphoma

Conducts research for Chronic Lymphocytic Leukemia

11 reported clinical trials

1 medical researcher

Photo of Ascension St John Hospital in Grosse PointePhoto of Ascension St John Hospital in Grosse PointePhoto of Ascension St John Hospital in Grosse Pointe

Summary

Ascension St John Hospital is a medical facility located in Grosse Pointe, Michigan. This center is recognized for care of Lymphoma, Breast Cancer, Childhood Blood Disease, Mixed-Cell Lymphoma, Chronic Lymphocytic Leukemia and other specialties. Ascension St John Hospital is involved with conducting 11 clinical trials across 24 conditions. There are 1 research doctors associated with this hospital, such as Daniel Lebovic.

Area of expertise

1

Lymphoma

Ascension St John Hospital has run 3 trials for Lymphoma.

2

Breast Cancer

Ascension St John Hospital has run 2 trials for Breast Cancer. Some of their research focus areas include:

Stage IV
Stage III
PD-L1 positive

Top PIs

Daniel Lebovic

Ascension St. John Hospital

4 years of reported clinical research

Studies Lymphoma
Studies Chronic Lymphocytic Leukemia
4 reported clinical trials
12 drugs studied

Clinical Trials running at Ascension St John Hospital

Follicular Lymphoma

Pneumonia

Marginal Zone Lymphoma

MALT Lymphoma

Image of trial facility.

Zanubrutinib + Anti-CD20

for Lymphoma

The purpose of the study is to compare the efficacy of zanubrutinib plus obinutuzumab versus lenalidomide plus rituximab (R\^2) in participants with relapsed/refractory (R/R) follicular lymphoma (FL), as measured by progression-free survival as determined by an independent review committee in accordance with the 2014 modification of the International Working Group on non-Hodgkin lymphoma (NHL) Criteria based on n positron emission tomography and computed tomography (PET/CT), and to compare the efficacy of zanubrutinib plus rituximab versus R\^2 in participants with R/R marginal zone lymphoma (MZL), as measured by progression free survival (PFS) assessed by IRC in accordance with CT-based Lugano 2014 Criteria.

Recruiting

2 awards

Phase 3

5 criteria

Similar Hospitals nearby

Select from list below to view details

Frequently asked questions

What kind of research happens at Ascension St John Hospital?

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.